Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

14.21
Delayed Data
As of Jul 30
 -0.60 / -4.05%
Today’s Change
1.86
Today|||52-Week Range
19.68
+169.13%
Year-to-Date
No recent news for InVivo Therapeutics Holdings Corp.

Today’s Trading

Previous close14.81
Today’s open14.50
Day’s range13.01 - 14.70
Volume468,480
Average volume (3 months)417,811
Market cap$393.4M
Dividend yield--
Data as of 3:59pm ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)+59.62%
Earnings growth (this year)+21.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book58.69

Competitors

 Today’s
change
Today’s
% change
AMRNAmarin Corporation P...+0.02+0.92%
ARWRArrowhead Research C...-0.08-1.37%
ONTYOncothyreon Inc-0.04-1.13%
BSTCBiospecifics Technol...+1.96+3.03%
Data as of 4:14pm ET, 07/30/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$18.3M
Net profit margin--

Profile

Sector
Industrial Services
Industry
Engineering & Construction
Chief Executive Officer &
Director
Mark D. Perrin
Senior Vice President-
Operations
William D'Agostino
Corporate headquarters
Cambridge, Massachusetts

Forecasts